In this webinar, our partners at the National Health Council focused on the impact of the Coronavirus on mental health in the US. The speakers discussed the increase in anxiety as well as gave general advice for self-care and advice for LGBTQ youth on coping with stress during the COVID-19 crisis. This webinar is intended […]
$500,000 grant awarded to the Solve ME/CFS Initiative to further epigenetic research
We are thrilled to announce that the Dr. Ralph & Marian Falk Medical Research Trust has awarded $500,000 to the Solve ME/CFS Initiative to further our epigenetic research. READ MORE…
Research Digest – December 2014: 10 Important Advances in ME/CFS
While progress is still far too slow, there have been many recent interesting and important discoveries in ME/CFS. In this year-end blog post, Dr. Vernon and Dr. Komaroff summarize what they regard as the most important recent advances in our field. READ MORE…
Being “Patient-Centric”
Patients are central to a solution for ME/CFS. We have designed our SolveCFS BioBank™ to collect and manage data so that the individual is the central organizing principle. LEARN MORE…
Deciphering Post-Exertional Malaise
On September 18, 2014, Dane B. Cook, Ph.D., Associate Professor of Kinesiology at the University of Wisconsin, Madison and a Solve ME/CFS Initiative 2011 funded investigator, presented our most popular webinar of the year on the system biology approach his team is taking to provide a clear picture as to what causes post-exertional malaise. In this guest post for our blog, Dr. Cook reviews the material presented and tackles the many questions we received from webinar participants.
The Importance of a Representative Patient Population for Research
Being able to offer researchers access to ME/CFS patients with demographic and clinical characteristics that represent the full range of people affected with ME/CFS removes a significant hurdle all researchers face. With the SolveCFS BioBank™ we can make ME/CFS research more appealing and accessible. But how do we ensure our SolveCFS BioBank™ is representative of the entire patient population? READ MORE….
Research Digest – September 2014: Cortisol in ME/CFS
Cortisol is an essential hormone for immune function and many studies have shown that cortisol is low in ME/CFS patients – known as hypocortisolism. In this month’s research digest, we review three studies that look at the effect of cortisol on function and post-exertional malaise in ME/CFS…
Research Digest – August 2014: More Results from the SolveCFS BioBank
More results from the work being done through the SolveCFS BioBank: We are pleased to report the publication of the initial BioBank study on XMRV and the publication of the first study of epigenetics in ME/CFS. Both used the clinical information and samples from the SolveCFS BioBank that were collected in 2010. READ MORE…
SolveCFS BioBank: Calling YOU to Participate in Gathering a Breadth & Depth of ME/CFS Data, Part 4 of 4
The SolveCFS BioBank allows us to seek out and attract the brightest investigators, allowing multiple research projects on participant samples where results are combined. ME/CFS is complex, like a jigsaw puzzle. When you participate in the BioBank, different research studies are brought together. READ MORE in part 4 of 4 of this series…
SolveCFS BioBank: Breaking Down Barriers Through Biomarker Discovery, Part 3 of 4
In the short time our SolveCFS BioBank has been in operation, it has proven to be an attractive resource drawing some of the best and brightest investigators into ME/CFS research. In this 3rd part of our SolveCFS BioBank series we feature two investigators who are working on biomarker discovery.